CDMO

Leadership evolution in India’s pharmaceutical sector in 2025- Driving global growth and innovation

Read more

Granules India acquires Senn Chemicals AG to expand peptide therapeutics and CDMO capabilities

Read more

Jubilant Biosys seals deal with Pierre Fabre SA

Read more

India is rising from a CDMO perspective when it comes to biologics

Read more

India’s pharma exports set to reach $350 billion by 2047, report finds

Read more

Veeda Group rebrands as Veeda Lifesciences

Read more

Akums Group enters into a partnership for European market expansion

Read more

OneSource pharma launches new brand identity at CPHI, Milan

Read more

Advantage India due to the Biosecure Act

Read more

Enzene appoints new site lead for flagship US continuous biomanufacturing facility

Read more